Dissection of T-cell antigen specificity in human melanoma

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Dissection of T-cell antigen specificity in human melanoma. / Andersen, Rikke Sick; Albæk Thrue, Charlotte; Junker, Niels; Skou, Rikke Birgitte Lyngaa; Donia, Marco; Ellebæk, Eva; Svane, Inge Marie; Schumacher, Ton N; Thor Straten, Per; Hadrup, Sine Reker.

In: Cancer Research, Vol. 72, No. 7, 2012, p. 1642-50.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Andersen, RS, Albæk Thrue, C, Junker, N, Skou, RBL, Donia, M, Ellebæk, E, Svane, IM, Schumacher, TN, Thor Straten, P & Hadrup, SR 2012, 'Dissection of T-cell antigen specificity in human melanoma', Cancer Research, vol. 72, no. 7, pp. 1642-50. https://doi.org/10.1158/0008-5472.CAN-11-2614

APA

Andersen, R. S., Albæk Thrue, C., Junker, N., Skou, R. B. L., Donia, M., Ellebæk, E., Svane, I. M., Schumacher, T. N., Thor Straten, P., & Hadrup, S. R. (2012). Dissection of T-cell antigen specificity in human melanoma. Cancer Research, 72(7), 1642-50. https://doi.org/10.1158/0008-5472.CAN-11-2614

Vancouver

Andersen RS, Albæk Thrue C, Junker N, Skou RBL, Donia M, Ellebæk E et al. Dissection of T-cell antigen specificity in human melanoma. Cancer Research. 2012;72(7):1642-50. https://doi.org/10.1158/0008-5472.CAN-11-2614

Author

Andersen, Rikke Sick ; Albæk Thrue, Charlotte ; Junker, Niels ; Skou, Rikke Birgitte Lyngaa ; Donia, Marco ; Ellebæk, Eva ; Svane, Inge Marie ; Schumacher, Ton N ; Thor Straten, Per ; Hadrup, Sine Reker. / Dissection of T-cell antigen specificity in human melanoma. In: Cancer Research. 2012 ; Vol. 72, No. 7. pp. 1642-50.

Bibtex

@article{67394f0c288d4ef29ad40c0cc2458b4b,
title = "Dissection of T-cell antigen specificity in human melanoma",
abstract = "Tumor-infiltrating lymphocytes (TIL) isolated from melanoma patients and expanded in vitro by interleukin (IL)-2 treatment can elicit therapeutic response after adoptive transfer, but the antigen specificities of the T cells transferred have not been determined. By compiling all known melanoma-associated antigens and applying a novel technology for high-throughput analysis of T-cell responses, we dissected the composition of melanoma-restricted T-cell responses in 63 TIL cultures. T-cell reactivity screens against 175 melanoma-associated epitopes detected 90 responses against 18 different epitopes predominantly from differentiation and cancer-testis antigens. Notably, the majority of these responses were of low frequency and tumor-specific T-cell frequencies decreased during rapid expansion. A further notable observation was a large variation in the T-cell specificities detected in cultures established from different fragments of resected melanoma lesions. In summary, our findings provide an initial definition of T-cell populations contributing to tumor recognition in TILs although the specificity of many tumor-reactive TILs remains undefined.",
author = "Andersen, {Rikke Sick} and {Alb{\ae}k Thrue}, Charlotte and Niels Junker and Skou, {Rikke Birgitte Lyngaa} and Marco Donia and Eva Elleb{\ae}k and Svane, {Inge Marie} and Schumacher, {Ton N} and {Thor Straten}, Per and Hadrup, {Sine Reker}",
year = "2012",
doi = "10.1158/0008-5472.CAN-11-2614",
language = "English",
volume = "72",
pages = "1642--50",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research",
number = "7",

}

RIS

TY - JOUR

T1 - Dissection of T-cell antigen specificity in human melanoma

AU - Andersen, Rikke Sick

AU - Albæk Thrue, Charlotte

AU - Junker, Niels

AU - Skou, Rikke Birgitte Lyngaa

AU - Donia, Marco

AU - Ellebæk, Eva

AU - Svane, Inge Marie

AU - Schumacher, Ton N

AU - Thor Straten, Per

AU - Hadrup, Sine Reker

PY - 2012

Y1 - 2012

N2 - Tumor-infiltrating lymphocytes (TIL) isolated from melanoma patients and expanded in vitro by interleukin (IL)-2 treatment can elicit therapeutic response after adoptive transfer, but the antigen specificities of the T cells transferred have not been determined. By compiling all known melanoma-associated antigens and applying a novel technology for high-throughput analysis of T-cell responses, we dissected the composition of melanoma-restricted T-cell responses in 63 TIL cultures. T-cell reactivity screens against 175 melanoma-associated epitopes detected 90 responses against 18 different epitopes predominantly from differentiation and cancer-testis antigens. Notably, the majority of these responses were of low frequency and tumor-specific T-cell frequencies decreased during rapid expansion. A further notable observation was a large variation in the T-cell specificities detected in cultures established from different fragments of resected melanoma lesions. In summary, our findings provide an initial definition of T-cell populations contributing to tumor recognition in TILs although the specificity of many tumor-reactive TILs remains undefined.

AB - Tumor-infiltrating lymphocytes (TIL) isolated from melanoma patients and expanded in vitro by interleukin (IL)-2 treatment can elicit therapeutic response after adoptive transfer, but the antigen specificities of the T cells transferred have not been determined. By compiling all known melanoma-associated antigens and applying a novel technology for high-throughput analysis of T-cell responses, we dissected the composition of melanoma-restricted T-cell responses in 63 TIL cultures. T-cell reactivity screens against 175 melanoma-associated epitopes detected 90 responses against 18 different epitopes predominantly from differentiation and cancer-testis antigens. Notably, the majority of these responses were of low frequency and tumor-specific T-cell frequencies decreased during rapid expansion. A further notable observation was a large variation in the T-cell specificities detected in cultures established from different fragments of resected melanoma lesions. In summary, our findings provide an initial definition of T-cell populations contributing to tumor recognition in TILs although the specificity of many tumor-reactive TILs remains undefined.

U2 - 10.1158/0008-5472.CAN-11-2614

DO - 10.1158/0008-5472.CAN-11-2614

M3 - Journal article

C2 - 22311675

VL - 72

SP - 1642

EP - 1650

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -

ID: 48579963